Here’s Our Rant About NuVasive, Inc. (NUVA)

NuVasive, Inc. (NASDAQ:NUVA) went up by 4.02% from its latest closing price compared to the recent 1-year high of $81.91. The company’s stock price has collected 9.76% of gains in the last five trading sessions. Press Release reported on 09/09/20 that NuVasive Expands Precice Portfolio with First-of-its-Kind Plate for Pediatric Limb Lengthening and Reconstruction Procedures

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

Is It Worth Investing in NuVasive, Inc. (NASDAQ :NUVA) Right Now?

Plus, the 36-month beta value for NUVA is at 1.23. Opinions of the stock are interesting as 8 analysts out of 17 who provided ratings for NuVasive, Inc. declared the stock was a “buy,” while 1 rated the stock as “overweight,” 7 rated it as “hold,” and 1 as “sell.”

The average price from analysts is $66.50, which is $9.77 above the current price. NUVA currently public float of 50.90M and currently shorts hold a 12.84% ratio of that float. Today, the average trading volume of NUVA was 773.62K shares.

NUVA’s Market Performance

NUVA stocks went up by 9.76% for the week, with a monthly jump of 8.57% and a quarterly performance of -3.59%, while its annual performance rate touched -13.61%. The volatility ratio for the week stands at 3.22% while the volatility levels for the past 30 days are set at 2.92% for NuVasive, Inc.. The simple moving average for the period of the last 20 days is 6.99% for NUVA stocks with a simple moving average of -9.44% for the last 200 days.

Analysts’ Opinion of NUVA

Many brokerage firms have already submitted their reports for NUVA stocks, with Northland Capital repeating the rating for NUVA by listing it as a “Market Perform.” The predicted price for NUVA in the upcoming period, according to Northland Capital is $65 based on the research report published on June 25th of the current year 2020.

Needham, on the other hand, stated in their research note that they expect to see NUVA reach a price target of $65. The rating they have provided for NUVA stocks is “Buy” according to the report published on June 23rd, 2020.

Robert W. Baird gave a rating of “ Outperform” to NUVA, setting the target price at $66 in the report published on April 8th of the current year.

NUVA Trading at 2.73% from the 50-Day Moving Average

After a stumble in the market that brought NUVA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -31.50% of loss for the given period.

Volatility was left at 2.92%, however, over the last 30 days, the volatility rate increased by 3.22%, as shares surge +5.59% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -1.70% lower at present.

During the last 5 trading sessions, NUVA rose by +9.76%, which changed the moving average for the period of 200-days by -22.60% in comparison to the 20-day moving average, which settled at $52.59. In addition, NuVasive, Inc. saw -27.45% in overturn over a single year, with a tendency to cut further losses.

Insider Trading

Reports are indicating that there were more than several insider trading activities at NUVA starting from Link Matthew, who sold 3,000 shares at the price of $67.00 back on Jun 08. After this action, Link Matthew now owns 82,595 shares of NuVasive, Inc., valued at $201,000 using the latest closing price.

Link Matthew, the President of NuVasive, Inc., sold 3,000 shares at $79.80 during a trade that took place back on Jan 16, which means that Link Matthew is holding 80,081 shares at $239,400 based on the most recent closing price.

Stock Fundamentals for NUVA

Current profitability levels for the company are sitting at:

  • +10.36 for the present operating margin
  • +61.97 for the gross margin

The net margin for NuVasive, Inc. stands at +5.58. The total capital return value is set at 7.92, while invested capital returns managed to touch 4.28. Equity return is now at value -0.40, with -0.20 for asset returns.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

Based on NuVasive, Inc. (NUVA), the company’s capital structure generated 76.88 points at debt to equity in total, while total debt to capital is 43.46. Total debt to assets is 37.32, with long-term debt to equity ratio resting at 3.14. Finally, the long-term debt to capital ratio is 76.20.

When we switch over and look at the enterprise to sales, we see a ratio of 3.94, with the company’s debt to enterprise value settled at 0.15. The receivables turnover for the company is 5.73 and the total asset turnover is 0.65. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.69.

Related Articles

Is a Correction Looming Ahead for DiamondPeak Holdings Corp. (DPHC)

DiamondPeak Holdings Corp. (NASDAQ:DPHC) went up by 9.59% from its latest closing price compared to the recent 1-year high of $31.80. The company’s stock...

Riding the Trend or Protecting Profits | The Goodyear Tire & Rubber Company (GT)

The Goodyear Tire & Rubber Company (NASDAQ:GT) went down by -0.54% from its latest closing price compared to the recent 1-year high of $17.20....

Heat Biologics Inc. (HTBX) Just Got Our Attention

Heat Biologics Inc. (NASDAQ:HTBX) went up by 3.23% from its latest closing price compared to the recent 1-year high of $4.30. The company’s stock...

Latest Posts

Is a Correction Looming Ahead for DiamondPeak Holdings Corp. (DPHC)

DiamondPeak Holdings Corp. (NASDAQ:DPHC) went up by 9.59% from its latest closing price compared to the recent 1-year high of $31.80. The company’s stock...

Riding the Trend or Protecting Profits | The Goodyear Tire & Rubber Company (GT)

The Goodyear Tire & Rubber Company (NASDAQ:GT) went down by -0.54% from its latest closing price compared to the recent 1-year high of $17.20....

Heat Biologics Inc. (HTBX) Just Got Our Attention

Heat Biologics Inc. (NASDAQ:HTBX) went up by 3.23% from its latest closing price compared to the recent 1-year high of $4.30. The company’s stock...

Highlights from the Ratings and Financial Report for CHF Solutions Inc. (CHFS)

CHF Solutions Inc. (NASDAQ:CHFS) went up by 0.07% from its latest closing price compared to the recent 1-year high of $2.27. The company’s stock...

Looking Closely at the Growth Curve for Titan Pharmaceuticals Inc. (TTNP)

Titan Pharmaceuticals Inc. (NASDAQ:TTNP) went up by 3.09% from its latest closing price compared to the recent 1-year high of $0.59. The company’s stock...